P.J. Schmidt Investment Management (PJS)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,039	Closed	-$255K	–	141
2015 Q4	$255K	Sell	5,039 -165	-3%	-$8.15K	0.1%	127
2015 Q3	$238K	Sell	5,204 -700	-12%	-$39.1K	0.1%	123
2015 Q2	$344K	Sell	5,904 -85	-1%	-$4.86K	0.13%	125
2015 Q1	$330K	Sell	5,989 -250	-4%	-$13.5K	0.13%	123
2014 Q4	$313K	Sell	6,239 -450	-7%	-$22K	0.12%	126
2014 Q3	$309K	Hold	6,689	–	–	0.13%	121
2014 Q2	$292K	Sell	6,689 -250	-4%	-$10.1K	0.11%	129
2014 Q1	$289K	Hold	6,939	–	–	0.11%	126
2013 Q4	$257K	Sell	6,939 -200	-3%	-$7.17K	0.11%	118
2013 Q3	$250K	Hold	7,139	–	–	0.11%	106
2013 Q2	$206K	Buy	+7,139	New	+$203K	0.1%	102

Other funds holding PBE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TAM

Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

HBT

Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return

CAS

Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s PBE Position: Q1 2016 in Review

P.J. Schmidt Investment Management (PJS) sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2016, closing a stake of 5,039 shares — an estimated $255K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in PBE in Q2 2013 and held it in 11 quarters. The position peaked at $344K in Q2 2015. 71 funds tracked by Wall St. Rank hold PBE as of Q1 2016.

P.J. Schmidt Investment Management (PJS) reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2016 after selling out during the quarter.
P.J. Schmidt Investment Management (PJS) sold 5,039 Invesco Biotechnology & Genome ETF shares in Q1 2016, an estimated $255K.
P.J. Schmidt Investment Management (PJS) first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and held it in 11 quarters.
P.J. Schmidt Investment Management (PJS)'s Invesco Biotechnology & Genome ETF position peaked at $344K in Q2 2015.
71 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2016.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q1 2016, filed 29 Apr 2016.